Form 4 for NXL Nexalin Technology, Inc.
Accepted 2022-09-20 00:00:00 ET · period of report 2022-09-16 · accession 0001829126-22-017005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-09-20 | 2022-09-16 | NXL | Owens David | Chief Medical Off, Dir | P - Purchase | $4.15 | +2,500 | 141.2K | +2% | +$10.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-16 | P | A | 2,500 | $4.15 | 141,174 | D | — | — |